Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing
Reexamination Certificate
2006-09-19
2006-09-19
Jones, Dameron L. (Department: 1618)
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
C424S001110, C424S001650
Reexamination Certificate
active
07108845
ABSTRACT:
There is provided a method of synthesis of a radiolabelled platinum chemotherapeutic agent comprising the steps of: converting a metal halide to a radiolabelled platinum halide wherein the radiolabel is a radioisotope of Pt; and synthesizing the radiolabelled platinum chemotherapeutic agent from the radiolabelled platinum halide.
REFERENCES:
patent: 4177263 (1979-12-01), Rosenberg et al.
patent: 4203912 (1980-05-01), Hydes et al.
patent: 4302446 (1981-11-01), Kaplan et al.
patent: 4310515 (1982-01-01), Granatek et al.
patent: 4322391 (1982-03-01), Kaplan et al.
patent: 4339437 (1982-07-01), Rosenberg et al.
patent: 4451447 (1984-05-01), Kaplan et al.
patent: 4562275 (1985-12-01), Speer et al.
patent: 4594418 (1986-06-01), Speer et al.
patent: 4607114 (1986-08-01), Nakayama et al.
patent: 4687780 (1987-08-01), Barnard
patent: 4696918 (1987-09-01), Stoddart et al.
patent: 4739087 (1988-04-01), Speer et al.
patent: 4863902 (1989-09-01), Amagase et al.
patent: 4871528 (1989-10-01), Tognella et al.
patent: 4892735 (1990-01-01), Harrap
patent: 4943428 (1990-07-01), Lucot et al.
patent: 4946689 (1990-08-01), Kaplan et al.
patent: 5041579 (1991-08-01), Nishi et al.
patent: 5072011 (1991-12-01), Abrams et al.
patent: 5080904 (1992-01-01), Iga et al.
patent: 5104896 (1992-04-01), Nijkerk et al.
patent: 5130145 (1992-07-01), Oftebro et al.
patent: 5143713 (1992-09-01), Phillips et al.
patent: 5158760 (1992-10-01), Phillips et al.
patent: 5194645 (1993-03-01), Barnard
patent: 5244919 (1993-09-01), Abrams et al.
patent: 5272056 (1993-12-01), Burrows et al.
patent: 5393909 (1995-02-01), Khokhar et al.
patent: 5434046 (1995-07-01), Enns et al.
patent: 5434256 (1995-07-01), Khokhar et al.
patent: 5455270 (1995-10-01), Kaplan et al.
patent: 5562925 (1996-10-01), Rosenberg et al.
patent: 5578590 (1996-11-01), Grunicke et al.
patent: 5601800 (1997-02-01), Katti et al.
patent: 5635493 (1997-06-01), Vournakis et al.
patent: 5665771 (1997-09-01), Murrer
patent: 5670502 (1997-09-01), Brown
patent: 5696131 (1997-12-01), Baguley et al.
patent: 6008395 (1999-12-01), Kidani
patent: 6074626 (2000-06-01), Order
patent: 626189 (1989-03-01), None
patent: 613810 (1989-11-01), None
patent: 0181166 (1986-05-01), None
patent: 0306605 (1989-03-01), None
patent: 2074028 (1981-10-01), None
patent: 182490 (1996-04-01), None
Benard et al, Cancer Treatment Reports, vol. 67, No. 5, 1983, pp. 457-466.
Kawai et al, Journal of Labelled Compounds and Radiopharmaceuticals, vol. XXXVI, No. 1, pp. 65-71.
Howell et al, Radiation Research, vol. 140, pp. 55-62 (1994).
Baer et al, Int. J. Appl. Radiat. Isotop., vol. 36, No. 3, pp. 181-184 (1985).
Baer, J. et al.Microscale Synthesis of Anti-Tumor Platinum Compounds Labelled with191Pt. Int. J. Appl. Radiat. Isot. vol. 36, No. 3 pp. 181-184 (1985).
Benard P. et al.Whole Body Autoradiographic Study of the Distribution of195mPt. in Healthy and Tumor-Bearing Mice Treating With Labeled Cisplatin1.Cancer Treatment Reports vol. 67, No. 5 (May 1983).
Howel, R.W. et al.Radiotoxicity of Platinum-195m-Labeled trans-Platinum(II)in Mammalian Cells, Radiation Research 140, 55-62 (1994).
Jackson H. et al.An Improved Synthetic Procedure For The Preparation of195mPt Labelled Anti-Tumour ComplexesJournal of Labelled Compounds and Radiopharmaceuticals, vol. 29, No. 10 pp. 1121-1130 (Jun. 25, 1991).
Kataoka, M. et al.Scintigraphic Study on the Distribution of Radiolabeled cis-Diamminedichloroplatinum(II)in the Tumor-bearing Rabbit: A Comparison between Intra-arterial Injection with Lipiodol and Intravenous Injection. Radiation Oncology; Radiation Medicine: vol. 11 No. 6. pp. 247-250 (1993).
Kawai, K. et al.,Synthesis of Platinum-195m Radiolabelled cis-Diammine(1.1-cyclobutanedicarboxylato)platinum(II)of High Radionuclidic Purity, Journal of Labelled Compounds and Radiopharmaceuticals vol. 36 No. 1, 65-71 (Aug. 15, 1994).
Kawai K. et al.Synthesis of195mPt Radiolabeled Cis-Diammine(Glycolato)Platinum(II)of High Radionuclidic Purity. J. Radioanal. Nucl. Chem., Letters 199 (3) pp. 207-215 (1995).
Lange, R.C. et al.The Antitumor Agent Cis-Pt(NH3)2Cl2-Distribution Studies and Dose Calculations for193mPt and195mPtSection of Nuclear Medicine, Yale University School of Medicine, New Haven, CT, Journal of Nuclear Medicine, vol. 14, No. 4 191-195 (1972).
Lange, R.C. et al.Synthesis and Distribution of Radiolabeled Antitumor Agent: cis-Diamminedichloroplatinum(II) Yale University School of Medicine, New Haven, CT. Journal of Nuclear Medicine, vol. 13, No. 5 328-330 (1972).
Leh, F.K.V. et al.Preparation and Distribution of195Ptm-Labeled BleomycinRadiopharmacy Program, Cancer Hospital and Research Institute, and School of Pharmacy, Los Angeles County, University of Southern California. International Journal of Pharmaceutics, 1 pp. 41-47 (1978).
Litterst, C.L. et al.Distribution and Disposition of Platinum following Intravenous Administration of cis-Diamminedichloroplatinum(II) (NSC 119875)to Dogs, Cancer Research vol. 36, 2340-2344, Jul. 1976
Owens, S.E. et al.In Vivo Distribution Studies of Radioactively Labelled Platinum Complexes; cis-dichlorodiammine platinum(II),cis-trans-dichlorodihydroxy-bis-(isopropylamine)platinum(IV),cis-dichloro-bis-cyclopropylamine platinum(II),and cis-diammine1, 1-cyclobutanedicarboxylate platinum(II)in patients with malignant disease, using a gamma camera. Cancer Chemotherapy and Pharcamology 14: 253-257 (1985).
Schlesinger, T. et al.,Dosimetry of Pt-195m: CIS-Dichlorodiammine-Platinum(Ii)And Other Platinum Compounds, Proc. Radiopharm. Dosimetry Symposium 1976, Oak Ridge, TN, pp. 452-461.
Shani J. et al.Noninvasive Monitoring of Drug Biodistribution and Metabolism: Studies with Intraaerterial Pt-195m-Cisplatin in Humans, Cancer Research 49, 1877-1881 (Apr. 1, 1989).
Sharma, H. et al.Blood Clearance of Radioactively Labelled cis-Diammine 1, 1-cyclobutane Dicarboxylate Platinum(II) (CBDCA)in Cancer PatientsCancer Chemotherapy and Pharmacology 11:5-7 (1983).
Smith, P.H.S. et al.Distribution and Retention of the Antitumor Agent195mPt-cis-Dichlorodiammine Platinum(II)In Man. Royal Marsden Hospital and Institute of Cancer Research, Sutton, Surrey, U.K., Journal of Nuclear Medicine, vol. 15, No. 5 349-352 (1974).
Suwa M. et al.A Microscale Synthesis of a Promising Radiolabelled Antitumor Drug: cis-1,1-cyclobutanedicarboxylato(2R)-2-Methyl-1, 4-butanediamine platinum(II),NK121. Journal of Labelled Compounds and Radiopharmaceuticals, vol. 31, No. 5 pp. 349-354 (Jan. 6, 1992).
Thatcher N. et al.Blood Clearance of Three Radioactively Labelled Platinum Complexes: cis-Dichlorodiammine Platinum II, cis, trans-Dichlorodihydroxy-bis-(isopropylamine)Platinum IV, and cis-Dichloro-bis-cyclopropylamine Platinum II, in Patients with Malignant Disease. Cancer Chemotherapy Pharmacology. 9: 13-16 (1982).
Toth, G. et al.Production and Examination of the Organ Distribution of Cis-Dichlor-Diammine-Platinum, Labeled with193PtmCertified Translation of Hungarian Language, Izotoptechnika Budapest 19 pp. 49-51 (1976) (translation).
Willins, J. D. et al.Modeling Analysis of Platinum-195m for Targeting Individual Blood-Borne Cells in Adjuvant Radioimmunotherapy. Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, NY. The Journal of Nuclear Medicine. vol. 36 No. 2 pp. 315-319 (Feb. 1995).
Wolf, W. et al.195PtmA New Radionuclide: Its Application to the Monitoring of Cancer Chemotherapeutic AgentsRecent Advances in Nuclear Medicine Proceedings of the First World Congress of Nuclear Medicine pp. 944-945 Sep. 30-Oct. 5, 1974, Tokyo and Kyoto, Japan.
Wolf, W. et al.Synthesis of Radiolabeled Platinum ComplexesRadiopharmacy Program, University of Southern California, Los Angeles, CA. Journal of Labelled Compounds and Radiopharmaceuticals, vol. 13, No. 2 p. 183 (1977).
Degner, Maria et al. Binary Halides of Platinum: Preparation, Thermal Decomposition and Structural Results. Transition Met. Chem 1. Aug. 11, 1975, pp. 41-47. Germany.
Cohen, Alvin J. et al. Platinum (II) Chloride. Inorganic Synthesis. 1960, pp. 209-215, vol. VI. McGraw-Hill Book Company, Inc. United States of America.
Schweizer, A.
Australian Nuclear Science & Technology Organisation
Banner & Witcoff , Ltd.
Jones Dameron L.
LandOfFree
Methods of synthesis and use of radiolabelled platinum... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of synthesis and use of radiolabelled platinum..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of synthesis and use of radiolabelled platinum... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3599702